Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD (ADXN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
10/09/2018 10/10/2018 10/11/2018 10/12/2018 10/15/2018 Date
2.61(c) 2.58(c) 2.6(c) 2.48(c) 2.5 Last
7 789 28 175 31 326 30 300 3 669 Volume
-1.14% -1.15% +0.78% -4.62% +0.81% Change
More quotes
Company
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health.It develops novel, orally available, and small molecule allosteric modulators for neurological disorders.The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
10/02ADDEX THERAPEUTICS : to Present at the Sachs 18th Annual Biotech in Europe Forum
AQ
09/28ADDEX THERAPEUTICS : Reports 2018 Half-Year Financial Results and Provides Corpo..
AQ
09/26ADDEX THERAPEUTICS : Recognised in Final Shortlist for Deal of the Year at Lifes..
AQ
09/25ADDEX THERAPEUTICS : to Present at the Investora Zurich Conference on 27 Septemb..
AQ
09/25ADDEX THERAPEUTICS : Recognised in final shortlist for deal of the year at lifes..
AQ
09/21ADDEX THERAPEUTICS : ADX10061 Receives 1.2 million Funding for Manufacture and I..
AQ
09/20ADDEX THERAPEUTICS : ADX10061 Receives £1.2 million Funding for Manufacture and ..
AQ
09/05ADDEX THERAPEUTICS : Addexs Selective mGlu2 PAM ADX71149 Shows Promise in Treati..
AQ
09/04ADDEX THERAPEUTICS : Selective mGlu2 PAM ADX71149 Shows Promise in Treating Seve..
AQ
08/28ADDEX THERAPEUTICS LTD : half-yearly earnings release
More news
Sector news : Biotechnology & Medical Research - NEC
10/11GILEAD SCIENCES : Allogene's Upsized IPO Prices at High End of Range
DJ
10/05ABBVIE : Receives Health Canada Approval of Orilissa for Endometriosis Pain Trea..
DJ
10/04J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion
RE
10/02GILEAD SCIENCES : Allogene Sets IPO at 16 Million Shares; Sees Pricing $16-$18
DJ
09/28FDA Approves Libtayo to Treat Advanced Cutaneous Squamous Cell Carcinoma
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
04/05$ADXN Therapeutics Ltd 1 director bought: A director at Addex Therapeutics L.. 
03/29Addex Therapeutics : Sucessfully Raises CHF40 million in Capital Increase  
03/20Addex Therapeutics : Swiss Takeover Board Validates New Article 39 (Opting-Ou.. 
02/23Addex Therapeutics : Publishes Extraordinary General Meeting Invitation  
02/20Dystonia - Pipeline Insight, 2018 Featuring Addex Therapeutics, Advicenne Pha.. 
More tweets
Qtime:5
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Managers
NameTitle
Timothy Dyer Chief Executive Officer & Director
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Jean-Philippe Rocher Head-Discovery
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD8.30%71
CELLTRION, INC.--.--%30 463
IQVIA HOLDINGS INC27.47%24 833
LONZA GROUP18.72%23 465
INCYTE CORPORATION-33.95%13 127
SEATTLE GENETICS, INC.36.02%11 255